TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma

Journal of the American Academy of Dermatology
Manuel António CamposPaula Soares

Abstract

Telomerase reverse transcriptase gene (TERT) promoter (TERTp) mutations have been reported as potential predictors of poor prognosis in several cancers, but the prognostic value of TERTp mutations for cutaneous squamous cell carcinoma (cSCC) has not been determined. To evaluate the frequency of TERTp mutations and correlate it with clinicopathologic features and patient outcome. We performed genetic profiling of TERTp mutations in a retrospective series of cSCCs. The predictive value of TERTp mutations and clinicopathologic parameters were assessed by using logistic regression models. A total of 152 cSCCs from 122 patients were analyzed for TERTp mutations; the mutation rate was 31.6% (48 of 152), and it was higher in invasive cSCC (42 of 121 [34.7%]) than in in situ cSCC (6 of 31 [19.4%]). Age older than 75 years (odds ratio [OR], 14.84; P = .013] and TERTp mutation (OR, 8.11; P = .002) were independent predictors of local recurrence. TERTp mutation (OR, 15.89; P = .022) was independently associated with higher risk of lymph node metastasis. The restricted number of metastatic cases. TERTp mutations may prove to be a molecular biomarker with prognostic significance in invasive cSCC, but larger studies are needed.

Citations

Nov 21, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·L Di NardoK Peris
Dec 19, 2019·Current Opinion in Oncology·Patrick M Mulvaney, Chrysalyne D Schmults
Mar 19, 2020·Frontiers in Oncology·Yujia WangXian Jiang
Mar 20, 2019·International Journal of Molecular Sciences·Alessandra VenturaMaria Concetta Fargnoli
Jul 2, 2021·Annals of Surgical Oncology·Flora YanAndrew T Day
Dec 25, 2021·Experimental Dermatology·Emi DikaBianca Maria Piraccini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Gaceta médica de México
Jaime Alonso Reséndiz-ColosiaSergio Arturo Rodríguez-Cuevas
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
K WermkerC Hallermann
© 2022 Meta ULC. All rights reserved